Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies Elizabeth A. LippnerDavid B. LewisTamiko R. Katsumoto Lung Cancer (HA Wakelee, Section Editor) 22 June 2019 Article: 62
The Role of Circulating Tumor DNA in Lung Cancer: Mutational Analysis, Diagnosis, and Surveillance Now and into the Future Katherine A. ScillaChristian Rolfo Lung Cancer (HA Wakelee, Section Editor) 15 June 2019 Article: 61
When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer? Laurent MhannaNicolas GuibertJulien Mazieres Lung Cancer (HA Wakelee, Section Editor) Open access 06 June 2019 Article: 60
Should Oncologists Recommend Cannabis? Donald I. Abrams Palliative and Supportive Care (MP Davis, Section Editor) 03 June 2019 Article: 59
Multimodality Management of Localized Biliary Cancer Nadia AshaiPreethi PrasadLakshmi Rajdev Upper Gastrointestinal Cancers (L Rajdev, Section Editor) 29 May 2019 Article: 58
Optimizing Therapies in the Perioperative Management of Gastric Cancer Uqba KhanManish A. Shah Upper Gastrointestinal Cancers (L Rajdev, Section Editor) 29 May 2019 Article: 57
Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients Thomas D. RyanRajaram NagarajanJustin Godown Cardio-oncology (MG Fradley, Section Editor) 25 May 2019 Article: 56
QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics Sanjay ChandrasekharMichael G. Fradley Cardio-oncology (MG Fradley, Section Editor) 25 May 2019 Article: 55
Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma Makoto EndoNokitaka SetsuYoshihiro Matsumoto Skin Cancer (T Ito, Section Editor) 25 May 2019 Article: 54
Correction to: Immunotherapy Advances in Urothelial Carcinoma Rohit K. JainTravis SnydersShilpa Gupta Correction 23 May 2019 Article: 53
